Starting Levothyroxine for Central Hypothyroidism
In this patient with central hypothyroidism (TSH 0.39, free T4 11.3 pmol/L - which is low), you must first rule out adrenal insufficiency before initiating levothyroxine, then start levothyroxine at the standard replacement dose of 1.6 mcg/kg/day (or lower if elderly/cardiac disease), titrating every 4-6 weeks to achieve a free T4 in the upper half of the normal range. 1, 2
Critical Pre-Treatment Step: Assess Adrenal Function
Before starting any levothyroxine therapy in central hypothyroidism, you must evaluate for adrenal insufficiency (AI). If this evaluation cannot be done immediately, prescribe empiric glucocorticoid therapy simultaneously with levothyroxine until definitive AI testing is completed 1. This is non-negotiable because:
- Thyroid hormone accelerates cortisol clearance
- Starting levothyroxine can unmask insufficient cortisol production
- This can precipitate life-threatening adrenal crisis
Starting Dose Algorithm
For Most Adults (Age <60, No Cardiac Disease):
- Start at 1.6 mcg/kg/day - the full replacement dose 2
- Some patients may require a lower starting dose initially
For High-Risk Patients:
- Elderly patients: Start at less than 1.6 mcg/kg/day 2
- Cardiac disease or atrial fibrillation risk: Start at a lower dose (less than 1.6 mcg/kg/day) and titrate more slowly every 6-8 weeks 2
Monitoring and Titration Strategy
TSH is NOT useful for monitoring central hypothyroidism - it will remain low/normal regardless of adequacy of replacement 2. Instead:
Primary Monitoring Target:
- Free T4 level - titrate to achieve levels in the upper half of the normal range 2
- This typically means aiming for free T4 in the upper 50th percentile of your laboratory's reference range
- Research supports that patients with central hypothyroidism require higher free T4 levels (upper normal range) compared to euthyroid individuals 3
Titration Schedule:
- Adjust dose by 12.5 to 25 mcg increments every 4-6 weeks until target achieved 2
- For cardiac patients: titrate every 6-8 weeks (slower) 2
- Peak therapeutic effect takes 4-6 weeks to manifest 2
Important Clinical Considerations
Growth Hormone Interaction:
If this patient has growth hormone deficiency and later starts GH therapy, monitor closely - 36-47% of euthyroid patients develop low free T4 within 3-6 months of starting GH 1. You will likely need to increase the levothyroxine dose.
Formulation Considerations:
If the patient fails to achieve target free T4 levels despite adequate tablet doses, consider switching to liquid or softgel formulations at the same dose - these have superior absorption and can increase free T4 by approximately 2-3 pmol/L compared to tablets 4.
Administration:
- Take on empty stomach, 30-60 minutes before breakfast
- Avoid simultaneous administration with medications that impair absorption (calcium, iron, proton pump inhibitors, etc.) 2
Common Pitfalls to Avoid
- Do NOT use TSH to guide therapy - this is the most critical error in central hypothyroidism management
- Do NOT start levothyroxine before ruling out adrenal insufficiency - can precipitate adrenal crisis
- Do NOT aim for mid-normal free T4 - target the upper half of normal range specifically 2, 3
- Do NOT under-replace - inadequate treatment leads to persistent hypothyroid symptoms and metabolic complications 5